{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:58:43Z","timestamp":1791489523934,"version":"4.3.4"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Autism spectrum disorder (ASD) is a severe brain development disorder that is characterized by deficits in social communication and restricted, repetitive and stereotyped behaviors. Accumulating evidence has suggested that gut microbiota disorders play important roles in gastrointestinal symptoms and neurodevelopmental dysfunction in ASD patients. Manipulation of the gut microbiota by fecal microbiota transplantation (FMT) was recently shown to be a promising therapy for the treatment of various diseases. Here, we performed a clinical trial to evaluate the effect of FMT on gastrointestinal (GI) and ASD symptoms and gut microbiota alterations in children with ASD. We found that there was a large difference in baseline characteristics of behavior, GI symptoms, and gut microbiota between children with ASD and typically developing (TD) control children. FMT could improve GI symptoms and ASD symptoms without inducing any severe complications. Similarly, FMT significantly changed the serum levels of neurotransmitters. We further observed that FMT could promote the colonization of donor microbes and shift the bacterial community of children with ASD toward that of TD controls. The abundance of\n                    <jats:italic>Eubacterium coprostanoligenes<\/jats:italic>\n                    pre-FMT was positively correlated with high GSRS scores, whereas a decrease in\n                    <jats:italic>Eubacterium coprostanoligenes<\/jats:italic>\n                    abundance induced by FMT was associated with the FMT response. Our data suggest that FMT might be a promising therapeutic strategy to improve the GI and behavioral symptoms of patients with ASD, possibly due to its ability to alter gut microbiota and highlight a specific microbiota intervention that targets\n                    <jats:italic>Eubacterium coprostanoligenes<\/jats:italic>\n                    that can enhance the FMT response. This trial was registered at the Chinese Clinical Trial Registry (\n                    <jats:uri>www.chictr.org.cn<\/jats:uri>\n                    ) (trial registration number ChiCTR1800014745).\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2021.759435","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T16:12:23Z","timestamp":1634746343000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":148,"title":["Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study"],"prefix":"10.3389","volume":"11","author":[{"given":"Ning","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senhong","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LinLing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s40168-021-01103-z","article-title":"The Microbial Metabolite P-Cresol Induces Autistic-Like Behaviors in Mice by Remodeling the Gut Microbiota","volume":"9","author":"Bermudez-Martin","year":"2021","journal-title":"Microbiome"},{"key":"B3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-030-30402-7_4","article-title":"Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors","volume":"24","author":"Bhandari","year":"2020","journal-title":"Adv. Neurobiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neubiorev.2021.07.001","article-title":"Altering the Gut Microbiome to Potentially Modulate Behavioral Manifestations in Autism Spectrum Disorders: A Systematic Review","volume":"128","author":"Davies","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00196","article-title":"Variable Colonization After Reciprocal Fecal Microbiota Transfer Between Mice With Low and High Richness Microbiota","volume":"8","author":"Ericsson","year":"2017","journal-title":"Front. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.2174\/1871527317666180706141654","article-title":"Overview of the Recent Advances in Pathophysiology and Treatment for Autism","volume":"17","author":"Famitafreshi","year":"2018","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/nu11030521","article-title":"Autism Spectrum Disorders and the Gut Microbiota","volume":"11","author":"Fattorusso","year":"2019","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","article-title":"Interactions Between the Microbiota, Immune and Nervous Systems in Health and Disease","volume":"20","author":"Fung","year":"2017","journal-title":"Nat. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41582-021-00530-8","article-title":"Maternal Immune Activation and Neuroinflammation in Human Neurodevelopmental Disorders","volume":"17","author":"Han","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11910-018-0887-6","article-title":"The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders","volume":"18","author":"Hughes","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/apt.14816","article-title":"Randomised Clinical Trial: Faecal Microbiota Transplantation by Colonoscopy Plus Vancomycin for the Treatment of Severe Refractory Clostridium Difficile Infection-Single Versus Multiple Infusions","volume":"48","author":"Ianiro","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/nu12030792","article-title":"Composition of Gut Microbiota in Children With Autism Spectrum Disorder: A Systematic Review and Meta-Analysis","volume":"12","author":"Iglesias-Vazquez","year":"2020","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota Transfer Therapy Alters Gut Ecosystem and Improves Gastrointestinal and Autism Symptoms: An Open-Label Study","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"key":"B14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.7326\/M16-0271","article-title":"Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium Difficile Infection: A Randomized Trial","volume":"165","author":"Kelly","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051552","article-title":"Probiotic and Oxytocin Combination Therapy in Patients With Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial","volume":"13","author":"Kong","year":"2021","journal-title":"Nutrients"},{"key":"B16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/MPG.0000000000001174","article-title":"Evaluation of Intestinal Function in Children With Autism and Gastrointestinal Symptoms","volume":"62","author":"Kushak","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00120","article-title":"The Gut Microbiota and Autism Spectrum Disorders","volume":"11","author":"Li","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism Spectrum Disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.chc.2020.02.005","article-title":"Gastrointestinal Issues and Autism Spectrum Disorder","volume":"29","author":"Madra","year":"2020","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10030163","article-title":"The Neurochemistry of Autism","volume":"10","author":"Marotta","year":"2020","journal-title":"Brain Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","article-title":"The Serotonin System in Autism Spectrum Disorder: From Biomarker to Animal Models","volume":"321","author":"Muller","year":"2016","journal-title":"Neuroscience"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110051","article-title":"Gut-Brain Axis: A Matter of Concern in Neuropsychiatric Disorders...!","volume":"104","author":"Naveed","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.cgh.2018.10.002","article-title":"The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications","volume":"17","author":"Osadchiy","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/advances\/nmy031","article-title":"Role of Probiotics in Managing Gastrointestinal Dysfunction in Children With Autism Spectrum Disorder: An Update for Practitioners","volume":"9","author":"Patusco","year":"2018","journal-title":"Adv. Nutr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrgastro.2016.191","article-title":"The Mucosal Immune System: Master Regulator of Bidirectional Gut-Brain Communications","volume":"14","author":"Powell","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut Microbiome Influences Efficacy of PD-1-Based Immunotherapy Against Epithelial Tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitter Modulation by the Gut Microbiota","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10803-018-3743-2","article-title":"Gastrointestinal Symptoms and Oral Antibiotic Use in Children With Autism Spectrum Disorder: Retrospective Analysis of a Privately Insured U.S. Population","volume":"49","author":"Vargason","year":"2019","journal-title":"J. Autism Dev. Disord."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00098","article-title":"Fecal Microbiota Transplantation in Neurological Disorders","volume":"10","author":"Vendrik","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.biopsych.2016.08.024","article-title":"Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder","volume":"81","author":"Vuong","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104784","article-title":"Probiotics and Fructo-Oligosaccharide Intervention Modulate the Microbiota-Gut Brain Axis to Improve Autism Spectrum Reducing Also the Hyper-Serotonergic State and the Dopamine Metabolism Disorder","volume":"157","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3969\/j.issn.1002-0829.2013.02.003","article-title":"Prevalence of Autism Spectrum Disorders Among Children in China: A Systematic Review","volume":"25","author":"Wan","year":"2013","journal-title":"Shanghai Arch. Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ebiom.2019.05.066","article-title":"Fecal Microbiota Transplantation Beyond Clostridioides Difficile Infections","volume":"44","author":"Wortelboer","year":"2019","journal-title":"EBioMedicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12876-021-01630-x","article-title":"Clinical Efficacy of Fecal Microbiota Transplantation for Patients With Small Intestinal Bacterial Overgrowth: A Randomized, Placebo-Controlled Clinic Study","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1038\/s41467-018-06103-6","article-title":"Gut Fungal Dysbiosis Correlates With Reduced Efficacy of Fecal Microbiota Transplantation in Clostridium Difficile Infection","volume":"9","author":"Zuo","year":"2018","journal-title":"Nat. Commun."}],"updated-by":[{"DOI":"10.3389\/fcimb.2021.801376","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000}}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.759435\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T09:41:35Z","timestamp":1638265295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.759435\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":35,"alternative-id":["10.3389\/fcimb.2021.759435"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2021.759435","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"article-number":"759435"}}